Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer

Not Applicable

• Conditions: Cancer
• Interventions: Other: Moxibustion

• Registration Number: NCT02261571
• Lead Sponsor: The Comprehensive and Integrative Medicine Institute of South Korea

Brief Summary

Most cancer patients experience multiple symptoms related to chemotherapy and use CAM (complementary and alternative medicine) as an adjunct to conventional treatment. Moxibustion is traditional Korean medical therapeutic method and uses the heat generated by burning herbal preparations containing Artemisia vulgaris to stimulated acupoint.

Herein, the investigators propose an open-label pilot study investigating the effectiveness of moxibustion stimulation at abdominal acupoint on quality of life in cancer patients under chemotherapy.

Detailed Description

Not available

Study Timeline

• Status Verified: 2014-10
• Study Start: 2014-10
• Study First Submitted: 2014-10-02
• Study First Submitted QC: 2014-10-09
• Last Update Submitted: 2014-10-09
• Study First Posted: 2014-10-10
• Last Update Posted: 2014-10-10
• Primary Completion: 2015-09
• Study Completion: 2015-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Diagnostic histopathology of cancer
• Performance status of 0-2 on the European Cooperative Oncology Group (ECOG) performance scale.
• Patients on chemotherapy currently have plan to receive chemotherapy for more than 6 weeks.
• Follow-up possible during the clinical trial
• Informed signed consent

Exclusion Criteria

• Patients with Severe Heart disease and hypertension that is not controlled (systolic blood pressure >160 or Diastolic blood pressure >100)
• Patients with diabetes that is not controlled (FBST >180 or BST>250)
• Patients with abdominal injury or severe ascites can't be received moxibustion therapy on abdomen.
• Hypersensitive section to moxibustion treatment
• Inability to comprehend or express oneself in the Korean language
• An Individual deemed to be ineligible by a physician
• Refusal to participate in this trial or to provide informed consent.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Moxibustion	Moxibustion	A series of moxibustion sessions within six weeks from baseline with adjuvant chemotherapy.

Primary Outcome Measures

Name	Time	Method
functional Assessment of Cancer Therapy: General (FACT-G)	change from baseline to 6 weeks

Secondary Outcome Measures

Name	Time	Method
Body mass index	change from baseline to 6 weeks
M.D, Anderson symptom Inventory (MDASI)	change from baseline to 6 weeks
immune function	change from baseline to 6 weeks	lymphocyte panel(CD3,4,8,19,26), WBC, Differential count

Trial Locations

Locations (1)

Deagu Hanny University Medical center; 🇰🇷 Deagu, Korea, Republic of